Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Savara Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.4
0
0
0.26
Research and development
8.18
18.5
37.2
38.8
35
29
27.9
44.3
78
81.4
Selling, general and administrative
9.34
General and administrative
2.82
11.1
10.7
13.1
14.3
12.4
10.9
15.7
25
42.1
Operating expenses
11.3
30
70
79
49.6
41.5
38.8
60
103
124
Operating income
-10.9
-30
-70
-79
-49.3
-41.5
-38.8
-60
-103
-124
Interest expense
0.45
1.16
Interest income
0.12
Other non-operating income
-0.33
-3.48
1.47
0.85
-0.32
-1.54
0.69
5.31
7.32
4.71
Pre-tax income
-11.3
-33.4
-68.6
-78.2
-49.6
-43
-38.2
-54.7
-95.9
-119
Income tax
-0.36
-3.63
-7.06
0.01
0
Net income
-10.9
-29.8
-61.5
-78.2
-49.6
-43
-38.2
-54.7
-95.9
-119
EBITDA
-10.8
-29.6
-69.5
-78
-49
-41.3
-38.8
-59.9
-103
-123
EPS, basic
-5.62
-1.76
-1.85
-1.95
-0.84
-0.32
-0.25
-0.33
-0.48
-0.53
EPS, diluted
-5.62
-1.76
-1.85
-1.95
-0.84
-0.32
-0.25
-0.33
-0.48
-0.53
Shares, basic (weighted)
1.96
17.5
33.3
40
59.3
134
153
165
198
222
Shares, diluted (weighted)
1.96
17.5
33.3
40
59.3
134
153
165
198
222
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
13.4
22.1
24.3
49.8
22.9
34
52.1
26.6
15.1
33.2
Short-term investments
0
72.2
86.5
72
59.3
127
73.8
136
181
203
Other current assets
0.84
3.55
2.51
2.31
2.93
3.83
3.08
3.63
5.81
5.91
Total current assets
14.6
97.9
113
124
85.1
165
129
166
202
242
Property, plant and equipment
0.79
0.93
0.52
0.35
0.16
0.07
0.05
0.27
0.17
0.1
Lease right-of-use assets
0.7
0.2
0.3
0.1
0.4
0.2
0.1
Goodwill
3.05
27.1
26.9
0
Other non-current assets
0.13
0.13
0.13
0.67
0.25
0.25
0.12
0.39
0.24
0.08
Total assets
28.9
160
152
136
97.7
177
140
178
213
253
Accounts payable
0.54
2.78
3.88
3.41
2.6
1.44
1.33
3.5
4.55
5.76
Accrued liabilities
2.48
2.97
3.38
5.47
5.58
4.88
4.53
7.09
10.2
14.6
Short-term debt
8.33
0
0
Total current liabilities
3.46
6.02
7.25
10.9
8.17
14.7
5.87
10.6
14.7
20.4
Long-term debt
25.1
17.3
26.1
26.3
26.6
29.9
Lease liabilities
0.3
0.1
0.1
0.05
0.2
0.1
Other non-current liabilities
0.07
0.51
0.08
0.12
0.05
0.25
0.09
0
Total liabilities
20.9
40.3
44.1
34.5
33.4
32.1
32
37.2
41.4
50.3
Total debt
25.1
25.7
26.1
26.3
26.6
29.9
Paid-in capital
3.12
187
238
310
321
445
447
534
661
811
Retained earnings
-38.4
-68.2
-130
-208
-258
-301
-339
-393
-489
-608
Other comprehensive income
-0.59
0.96
0.2
-0.02
0.94
0.01
-0.61
-0.27
-0.75
-0.09
Shareholders' equity
-35.9
119
108
102
64.4
144
108
140
171
203
Total equity
-35.9
119
0.2
-0.02
0.94
0.01
-0.61
-0.27
-0.75
-0.09
Total liabilities and equity
28.9
160
152
136
97.7
177
140
178
213
253
Shares outstanding
3.16
30.5
35.1
50.8
54.2
114
114
138
172
205
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-10.9
-29.8
-61.5
-78.2
-49.6
-43
-38.2
-54.7
-95.9
-119
Depreciation and amortization
0.1
0.36
0.53
1.01
0.26
0.14
0.03
0.08
0.13
0.09
Stock-based compensation
0.21
0.55
3.74
4.44
5.11
3.26
2.04
4.18
9.86
14.4
Deferred income tax
-2.41
-2.82
-7.06
Change in payables
-1.97
0.16
Cash from operations
-8.37
-28.2
-39.3
-45.1
-39.8
-40.1
-34.6
-51.1
-89.1
-101
Capital expenditures
-0.01
-0.5
-0.14
-0.15
-0.05
-0.06
-0.01
-0.3
-0.03
-0.02
Purchases of investments
-76.9
-122
-86.1
-161
-89.4
-194
-205
-205
Sales and maturities of investments
4.8
98.7
125
89.7
83.5
131
137
165
182
Cash from investing
-0.01
-69.1
-13.6
15.7
9.05
-69.5
52.6
-57.1
-39.9
-18.4
Debt issued
26.4
29.6
Debt repaid
-3.57
-0.51
-26.4
-27.2
Stock issued
20
1.67
0.51
29.6
2.29
0.02
0
0.28
0.35
0.35
Cash from financing
5.12
106
55.2
54.9
3.69
121
0.09
82.8
118
138
Net change in cash
-3.31
8.75
2.18
25.5
-26.9
11.1
18.1
-25.5
-11.5
18.1
Free cash flow
-8.38
-28.7
-39.4
-45.3
-39.9
-40.1
-34.6
-51.4
-89.1
-101
Interest paid
1.21
0.73
1.41
2.1
2,470
1.97
1.61
2.04
2.12
3.2
Income taxes paid
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.92 on November 10, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-141.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-98.0%
Net income / average total assets.
Return on invested capital (ROIC)
-114.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
18.5%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
23.5%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
25.8%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
19.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
21.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
21.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
12.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
13.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
30.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
8.55x
Current assets / current liabilities.
Quick ratio
7.80x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
7.80x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.28x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
19.4%
Total debt / total assets.
Liabilities / assets
30.8%
Total liabilities / total assets.
Net debt
-$99.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share
-$0.52
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.51
Cash from operations / diluted weighted shares.
Book value per share
$0.52
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
9.37x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
9.37x
Market cap / tangible book value, when positive.
FCF yield
-13.0%
Free cash flow / market cap.
Earnings yield
-15.1%
Net income / market cap (the inverse of P/E).
Was Savara Inc profitable in fiscal 2025?
No. It reported a net loss of $118.8M.
How much free cash flow did Savara Inc generate in fiscal 2025?
Cash from operations of $101.0M minus capital expenditures of $22.0K left free cash flow of -$101.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.